Browsing: abbott laboratories

Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.

If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.

After a long delay, Centocor Ortho Biotech’s psoriasis drug Stelara has been approved by the U.S. Food and Drug Administration.